Literature DB >> 20864053

Haemodynamic stroke: clinical features, prognosis, and management.

Catharina J M Klijn1, L Jaap Kappelle.   

Abstract

Haemodynamic stroke is a type of ischaemic stroke that is caused by hypoperfusion rather than by embolism or local vasculopathy. It can be caused by systemic diseases such as heart failure or hypotension, but also by severe obstruction of the carotid or vertebral arteries. Patients with haemodynamic stroke or transient ischaemic attack might show specific clinical features that distinguish them from patients with embolism or local small-vessel disease. Ancillary investigations of cerebral perfusion can show whether blood flow to the brain is compromised and provide important prognostic information. Management of patients who have hypoperfusion as the major cause of ischaemic stroke or as a contributing factor is hampered by the lack of clinical trials. Treatment aimed at increasing cerebral blood flow might be considered in selected patients on the basis of information from case series. Further research is needed to define criteria for the diagnosis of haemodynamic stroke and to investigate treatment options in controlled studies.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20864053     DOI: 10.1016/S1474-4422(10)70185-X

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  30 in total

Review 1.  Revascularization of collaterals for hemodynamic stroke: insight on pathophysiology from the carotid occlusion surgery study.

Authors:  Jose G Romano; David S Liebeskind
Journal:  Stroke       Date:  2012-05-29       Impact factor: 7.914

2.  Endovascular stenting for atherosclerotic subclavian artery stenosis in patients with other craniocervical artery stenosis.

Authors:  Yongkun Li; Qin Yin; Wusheng Zhu; Yinzhou Wang; Xiaobing Fan; Dezhi Liu; Maogang Chen; Qizhang Wang; Gelin Xu; Bernard Yan; Xinfeng Liu
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

3.  Duplex ultrasound assisted endovascular revascularization of chronic internal carotid artery occlusion: technical note.

Authors:  Nassir Rostambeigi; Rakesh Khatri; Ameer E Hassan; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2013-12

4.  Long-term hemodynamic changes and blood pressure in atherosclerotic major cerebral artery disease.

Authors:  Hiroshi Yamauchi; Shinya Kagawa; Masaaki Takahashi; Tatsuya Higashi
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-18       Impact factor: 6.200

5.  DSC perfusion-based collateral imaging and quantitative T2 mapping to assess regional recruitment of leptomeningeal collaterals and microstructural cortical tissue damage in unilateral steno-occlusive vasculopathy.

Authors:  Alexander Seiler; Annemarie Brandhofe; René-Maxime Gracien; Waltraud Pfeilschifter; Elke Hattingen; Ralf Deichmann; Ulrike Nöth; Marlies Wagner
Journal:  J Cereb Blood Flow Metab       Date:  2020-01-27       Impact factor: 6.200

6.  Progressive Cortical Neuronal Damage and Extracranial-Intracranial Bypass Surgery in Patients with Misery Perfusion.

Authors:  H Yamauchi; S Kagawa; Y Kishibe; M Takahashi; T Higashi
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-02       Impact factor: 3.825

7.  New insights in perinatal arterial ischemic stroke by assessing brain perfusion.

Authors:  Pia Wintermark; Simon K Warfield
Journal:  Transl Stroke Res       Date:  2011-11-10       Impact factor: 6.829

8.  Risk of ischemic stroke during the initiation period of α-blocker therapy among older men.

Authors:  Chao-Lun Lai; Raymond Nien-Chen Kuo; Ho-Min Chen; Ming-Fong Chen; K Arnold Chan; Mei-Shu Lai
Journal:  CMAJ       Date:  2015-12-07       Impact factor: 8.262

9.  Limb-shaking TIA: a case of cerebral hypoperfusion in severe cerebrovascular disease in a young adult.

Authors:  Tom E Richardson; Paul Beech; Geoffrey C Cloud
Journal:  BMC Neurol       Date:  2021-07-03       Impact factor: 2.474

Review 10.  Selective neuronal loss in ischemic stroke and cerebrovascular disease.

Authors:  Jean-Claude Baron; Hiroshi Yamauchi; Masayuki Fujioka; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.